RxStrategies v. CVS PharmacyDate Filed: May 3, 2018
District Court: M.D. Florida – 18-cv-01087
Nature of Suit: Antitrust
Defendant Type: Pharma
Court Document: https://www.bloomberglaw.com/public/desktop/document/RxStrategies_Inc_v_CVS_Pharmacy_Inc_et_al_Docket_No_818cv01087_MD/1?1527629997
340B administrator RxStrategies sued CVS pharmacy alleging that since CVS aquired Wellpartner, the company has engaged in unlawful tying, using its status as a “must have” 340B contract pharmacy to require that covered hospitals also use Wellpartner as their program administrator. The tying allegations are exactly the type of anticompetitive conduct that concerns antitrust enforcers following a vertical merger.